Endothelial Function and Circulating Microparticle in Patients Under LVAD Support
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- End Stage Heart Failure
- 发起方
- Heinrich-Heine University, Duesseldorf
- 入组人数
- 65
- 试验地点
- 1
- 主要终点
- Occurrence of thrombemboic events during 12 month
- 状态
- 已完成
- 最后更新
- 6年前
概览
简要总结
The aims of this project are 1) to evaluate whether circulating micraparticals (MPs) in patients with LVAD impair endothelial function and 2) to assess the procoagulative activity of circulating MPs in patients with LVAD in a prospective longitudinal study of patients undergoing LVAD implantation, 3) to analyze these parameters in the context of thromboembolic events.
详细描述
Continuous-flow left ventricular assist devices (LVADs) have arised as a vital therapeutic option in end stage heart failure not merely as bridge-to transplant but also as destination therapy. LVADs are associated with impaired endothelial function as well as with a dysbalance of coagulation leading to both, excessive bleeding and thromboembolic events, respectively. Microparticles (MPs) are shed membrane particles budded into the circulation and considered as a marker of compromised endothelial integrity and enhanced procoagulation levels. In addition, MPs have been suggested to play an active role in the induction of endothelial dysfunction and coagulation. First studies demonstrated increased level of MPs in patients with LVAD. Whether circulating MPs contribute to impaired endothelial function and enhanced coagulation in patients with LVAD and thereby promote thrombotic complications is unknown. The aims of this project are 1) to evaluate whether circulating MPs in patients with LVAD impair endothelial function and 2) to assess the procoagulative activity of circulating MPs in patients with LVAD in a prospective longitudinal study of patients undergoing LVAD implantation, 3) to analyze these parameters in the context of thromboembolic events.
研究者
Klinik für Kardiologie, Pneumologie und Angiologie
Dr.med. Patrick Horn, Principle Investigator
Heinrich-Heine University, Duesseldorf
入排标准
入选标准
- •Inclusion Criteria: chronic heart failure INTERMASC 5-7 or
- •Patients on LVAD support
排除标准
- •current thrombembolic or bleeding event
结局指标
主要结局
Occurrence of thrombemboic events during 12 month
时间窗: 12 month
次要结局
- Level of circulating mircoparticles(Baseline)
- Endothelial function(Baseline)
- microparticle induced thrombin generation(Baseline)